Jim Burns
President and CEO
CRISPR-Cas9 therapeutics
Casebia Therapeutics
United States of America
Biography
Jim Burns is President and CEO at Casebia. Burns has nearly 30 years of R&D experience in the biopharmaceutical industry and a proven track record of leading organizations that have successfully delivered therapeutics to patients across multiple therapeutic modalities. Prior to joining Casebia, Burns spent more than 25 years at Sanofi-Genzyme. First joining Genzyme in 1986, he advanced in multiple leadership roles to become Head of Sanofi’s North American R&D Hub, where he was responsible for coordinating R&D operations across key therapeutic areas. Burns earned his Bachelor of Science in Biology from Purdue University, and Doctorate in Bioengineering from the University of Illinois-Chicago, where his thesis work focused on drug delivery. Following his graduate studies, Burns was a post-doctoral researcher at the University of Florida. He was elected to the National Academies’ National Academy of Engineering in 2010.
Research Interest
CRISPR Therapeutics, gene editing therapeutics, inherited diseases
